Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

Development and manufacture of synthetic peptides - Scientific guideline

Parallel scientific advice and special development aspects or product types

Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn

EMA actively monitoring cruise ship Hantavirus outbreak

Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn